A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer; Melanoma Stage III; Melanoma Stage IV; Cutaneous Melanoma; Osteosarcoma; Carcinoma, Squamous Cell; Carcinoma, Basal Cell Intervention: Biological: KB707 Sponsor: Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Soluble B7-H3 as a Biomarker for Osteosarcoma
Conditions: Biomarker; Progression; Osteosarcoma; Surveillance Intervention: Diagnostic Test: ELISA: enzyme-linked immunosorbent assay Sponsors: Peking University People's Hospital; Shanghai Hansen Biopharmaceutical Technology Co., Ltd; MEDx Translational Medicine Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
